Entities / Company
Bayer.
German multinational pharmaceutical, chemical, and agricultural biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 131
What's happening
Gone quiet
No new reports in 90+ days-
Regeneron, Bayer, and FDA are involved in the joint development of Eylea HD, following an FDA inspection of a third-party manufacturer.Some support2 reports3 developments inside
-
ISM data analyzed tariff dynamics, prompting analysts to lower Q2 earnings expectations for major multinationals like Bayer and Estee Lauder.Some support1 report
-
Sam Whiting was appointed Chief Medical Officer at Vividion Therapeutics, a wholly owned subsidiary of Bayer.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Bayer this week
News at the entities that move Bayer mostConnections
The 1 strongest of 131, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Regeneron Pharmaceuticals Operational
Bayer and Regeneron are engaged in a joint development partnership for the drug Eylea HD, with Regeneron holding US exclusive rights.
History
Events by the month they beganJune 2026
3 events- Regeneron, Bayer, and FDA are involved in the joint development of Eylea HD, following an FDA inspection of a third-party manufacturer.
- ISM data analyzed tariff dynamics, prompting analysts to lower Q2 earnings expectations for major multinationals like Bayer and Estee Lauder.
- Sam Whiting was appointed Chief Medical Officer at Vividion Therapeutics, a wholly owned subsidiary of Bayer.